Study on Inflammatory Factors in Aneurysmal Perimembranous Ventricular Septal Defect in Congenital Heart Disease

To detect the expression of inflammatory factors such as interleukin-1β (IL-1β), interleukin-6 (IL-6), transforming growth factor (TGF-β), and tumor necrosis factor (TNF-α) in the tumor tissue of ventricular septal defect (VSD) in congenital heart disease and to explore the role of inflammatory response in the formation of aneurysmal perimembranous VSD(APVSD). Children with APVSD of congenital heart disease treated by surgery were selected and divided into true aneurysmal perimembranous group (TAP group) and pseudoaneurysmal perimembranous group (PAP group) according to echocardiography and surgical findings. There were 15 children in the TAP group and 31 in the PAP group. The aneurysmal perimembranous tissue of the two groups of children was collected during the operation. IL-1β, IL-6, TGF-β, and TNF-α were positively expressed in the aneurysmal perimembranous tissue of the two groups, and the expression levels of all inflammatory factors in the PAP group were higher than those in the TAP group, and the difference was statistically significant (P < 0.05). The expression levels of IL-1β, IL-6, TGF-β, and TNF-α in the aneurysmal perimembranous tissue of the two groups were negatively correlated with the width of the APVSD breach. IL-1β, IL-6, TGF-β, and TNF-α may be involved in the occurrence and development of APVSD through inflammatory mechanism.

[1]  A. Belyaev,et al.  Postmyocardial infarction ventricular septal defect and ventricular aneurysm repair with a “double‐patch frame” technique , 2022, Journal of cardiac surgery.

[2]  Y. Sawa,et al.  Giant Left Ventricular Pseudoaneurysm 10 Years After Post-Infarct Ventricular Septal Defect Repair , 2021, Circulation Journal.

[3]  John D Vossler,et al.  Traumatic Left Ventricular Aneurysm and Ventricular Septal Defect in a Child , 2021, World journal for pediatric & congenital heart surgery.

[4]  A. Rathod,et al.  Supracristal Ventricular Septal Defect Complicated by Formation of an Aorto-Right Ventricular Outflow Tract Fistula: A Rare Cause of Biventricular Enlargement , 2021, Methodist DeBakey cardiovascular journal.

[5]  S. Saba,et al.  Isolated Ventricular Septal Aneurysm: A Differential Diagnosis for a Right Sinus of Valsalva Aneurysm , 2021, The American journal of case reports.

[6]  Hiroshi Tanaka,et al.  Giant pseudoaneurysm that developed seven years after surgical repair of a postinfarction ventricular septal defect , 2021, General Thoracic and Cardiovascular Surgery.

[7]  Ewelina Pirsztuk,et al.  The role of temporary mechanical circulatory support in the effective surgical treatment of left ventricular aneurysm and ventricular septal defect in a patient after anterior wall myocardial infarction. , 2021, Kardiologia polska.

[8]  C. Ravishankar,et al.  Large aneurysms and pseudoaneurysms of surgically reconstructed right ventricular outflow tracts. , 2021, Cardiology in the young.

[9]  M. Tateishi,et al.  Repair of a unique sinus of Valsalva defect in an infant , 2021, Journal of cardiac surgery.

[10]  Changwei Zhang,et al.  Repair of traumatic ventricular septal defect and left ventricular aneurysm after blunt chest trauma. , 2020, Interactive cardiovascular and thoracic surgery.

[11]  A. Ilić,et al.  Left ventricular diverticulum vs. ventricular septal defect vs. ventricular aneurysm , 2020, The International Journal of Cardiovascular Imaging.

[12]  J. Sinisalo,et al.  Non-invasive dye dilution method for measuring an atrial septal defect shunt size , 2020, Open Heart.

[13]  Praveen C Sivadasan,et al.  Ruptured Sinus Of Valsalva Into The Right Ventricle A New Management Strategy. , 2020, Revista portuguesa de cirurgia cardio-toracica e vascular : orgao oficial da Sociedade Portuguesa de Cirurgia Cardio-Toracica e Vascular.

[14]  Qi An,et al.  Surgical removal of part of an occluder to treat iatrogenic coarctation of the aorta: a case report , 2020, BMC surgery.

[15]  M. Chu,et al.  Short- and medium-term follow-up of transcatheter closure of perimembranous ventricular septal defects , 2019, BMC Cardiovascular Disorders.

[16]  G. Andelfinger,et al.  The expanding phenotypes of cohesinopathies: one ring to rule them all! , 2019, Cell cycle.

[17]  J. Guccione,et al.  Tricuspid Valve Regurgitation Decreases after MitraClip Implantation: Fluid Structure Interaction Simulation. , 2019, Mechanics research communications.

[18]  D. Judge,et al.  Protein molecular modeling techniques investigating novel TAB2 variant R347X causing cardiomyopathy and congenital heart defects in multigenerational family , 2018, Molecular genetics & genomic medicine.

[19]  L. Liang,et al.  Genome-wide methylation analysis identifies novel CpG loci for perimembranous ventricular septal defects in human. , 2017, Epigenomics.

[20]  D. Tester,et al.  Whole Exome Sequencing, Familial Genomic Triangulation, and Systems Biology Converge to Identify a Novel Nonsense Mutation in TAB2-encoded TGF-beta Activated Kinase 1 in a Child with Polyvalvular Syndrome. , 2016, Congenital heart disease.

[21]  Sathiya Maran,et al.  Screening of SMAD7 in Malay patients with ventricular septal defect. , 2016, American journal of cardiovascular disease.

[22]  A. Engelman,et al.  Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice , 2015, PLoS ONE.